[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE172454T1 - Pyridazinon derivate mit pharmazeutischer wirkung - Google Patents

Pyridazinon derivate mit pharmazeutischer wirkung

Info

Publication number
ATE172454T1
ATE172454T1 AT94918564T AT94918564T ATE172454T1 AT E172454 T1 ATE172454 T1 AT E172454T1 AT 94918564 T AT94918564 T AT 94918564T AT 94918564 T AT94918564 T AT 94918564T AT E172454 T1 ATE172454 T1 AT E172454T1
Authority
AT
Austria
Prior art keywords
group
atom
alkyl group
pct
hydrogen atom
Prior art date
Application number
AT94918564T
Other languages
English (en)
Inventor
Keizo Tanikawa
Akira Saito
Mitsuaki Hirotsuka
Ken-Ichi Shikada
Original Assignee
Nissan Chemical Ind Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd
Application granted granted Critical
Publication of ATE172454T1 publication Critical patent/ATE172454T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22Nitrogen and oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT94918564T 1993-06-29 1994-06-24 Pyridazinon derivate mit pharmazeutischer wirkung ATE172454T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP15919493 1993-06-29
JP11272194 1994-05-26

Publications (1)

Publication Number Publication Date
ATE172454T1 true ATE172454T1 (de) 1998-11-15

Family

ID=26451823

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94918564T ATE172454T1 (de) 1993-06-29 1994-06-24 Pyridazinon derivate mit pharmazeutischer wirkung

Country Status (22)

Country Link
US (2) US5728702A (de)
EP (1) EP0706517B1 (de)
KR (1) KR100255416B1 (de)
CN (1) CN1044906C (de)
AT (1) ATE172454T1 (de)
AU (1) AU676341B2 (de)
CA (1) CA2166326C (de)
CZ (1) CZ289231B6 (de)
DE (1) DE69414112T2 (de)
DK (1) DK0706517T3 (de)
ES (1) ES2124413T3 (de)
FI (1) FI113963B (de)
HU (1) HU221009B1 (de)
IL (1) IL110040A (de)
NO (1) NO306675B1 (de)
NZ (1) NZ267510A (de)
RO (1) RO114791B1 (de)
RU (1) RU2138486C1 (de)
SK (1) SK280786B6 (de)
TW (1) TW408114B (de)
UA (1) UA34481C2 (de)
WO (1) WO1995001343A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100318653B1 (ko) * 1994-01-25 2002-04-22 도쿠시마 히데이치 피리다지논유도체
DE4430755A1 (de) * 1994-08-30 1996-03-07 Boehringer Mannheim Gmbh Neue Phosphanoxide, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US6207665B1 (en) 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
US6310065B1 (en) * 1998-03-31 2001-10-30 Nissan Chemical Industries, Ltd. Pyridazinone hydrochloride compound and method for producing the same
CA2390934C (en) * 1999-11-11 2008-07-15 Nissan Chemical Industries, Ltd. Process for producing benzylamine compound
EE200400088A (et) 2001-10-22 2004-10-15 Pfizer Products Inc. CCR1 retseptori suhtes antagonistlikku aktiivsustomavad piperasiiniderivaadid
US20060080140A1 (en) * 2004-02-09 2006-04-13 Epic Systems Corporation System and method for providing a clinical summary of patient information in various health care settings
WO2010099388A1 (en) * 2009-02-27 2010-09-02 Indigo Pharmaceuticals Combinational use of a pde3 inhibitor and other agents
CN116768868B (zh) * 2023-08-15 2023-12-08 云南省药物研究所 一种哒嗪酮硫代衍生物及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1265798A (en) * 1984-12-10 1990-02-13 Motoo Mutsukado 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it
JPH0641454B2 (ja) * 1985-02-27 1994-06-01 日産化学工業株式会社 ピリダジノン誘導体
US4892947A (en) * 1985-04-27 1990-01-09 Nissan Chemical Industries Ltd. 3(2H)Pyridazinone, process for its preparation and anti-allergic agent containing it
US4978665A (en) * 1987-01-20 1990-12-18 Nissan Chemical Industries Ltd. 3(2H)pyridazinone, and antagonistic agent against SRS-A containing it
JPH02256668A (ja) * 1988-12-20 1990-10-17 Nissan Chem Ind Ltd ピリダジノン誘導体
KR970002876B1 (ko) * 1990-04-25 1997-03-12 닛산가가꾸고오교 가부시끼가이샤 피리다지논 유도체
KR100318653B1 (ko) * 1994-01-25 2002-04-22 도쿠시마 히데이치 피리다지논유도체

Also Published As

Publication number Publication date
DE69414112T2 (de) 1999-03-11
EP0706517B1 (de) 1998-10-21
IL110040A0 (en) 1994-10-07
AU6983394A (en) 1995-01-24
DK0706517T3 (da) 1999-06-28
NZ267510A (en) 1996-10-28
TW408114B (en) 2000-10-11
SK280786B6 (sk) 2000-07-11
NO955328L (no) 1996-02-28
SK162495A3 (en) 1996-11-06
HU221009B1 (hu) 2002-07-29
CN1126470A (zh) 1996-07-10
NO306675B1 (no) 1999-12-06
HU9503807D0 (en) 1996-02-28
KR960703401A (ko) 1996-08-17
FI956300A (fi) 1995-12-28
NO955328D0 (no) 1995-12-28
US5728702A (en) 1998-03-17
WO1995001343A1 (en) 1995-01-12
AU676341B2 (en) 1997-03-06
CN1044906C (zh) 1999-09-01
DE69414112D1 (de) 1998-11-26
IL110040A (en) 2000-07-16
RO114791B1 (ro) 1999-07-30
US5929074A (en) 1999-07-27
CZ289231B6 (cs) 2001-12-12
FI113963B (fi) 2004-07-15
EP0706517A1 (de) 1996-04-17
RU2138486C1 (ru) 1999-09-27
CZ329995A3 (en) 1996-04-17
KR100255416B1 (ko) 2000-05-01
UA34481C2 (uk) 2001-03-15
FI956300A0 (fi) 1995-12-28
CA2166326C (en) 2005-02-01
CA2166326A1 (en) 1995-01-12
ES2124413T3 (es) 1999-02-01
HUT73483A (en) 1996-08-28

Similar Documents

Publication Publication Date Title
HUP0103884A2 (hu) Arilszulfonanilidkarbamid-származékok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0402313A2 (hu) Szerotonin újrafelvételt gátló fenilpiperazin-származékok, az ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
DE69929689D1 (de) Heterozyclische derivate für die behandlung von herzversagen und andere erkrankungen
HUP0302969A2 (hu) NPY Y5 antagonisták, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
HUP0400828A2 (hu) Kondenzált heterociklikus aminopirimidinek, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
ATE169008T1 (de) 3,5-dioxo-(2h,4h)-1,2,4-triazinderivate ihre herstellung und verwendung als medikament
ATE172454T1 (de) Pyridazinon derivate mit pharmazeutischer wirkung
NO995638L (no) Heterobicykliske forbindelser til fremstilling av pyridonkarboksylsyrederivater
MXPA02012569A (es) Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas.
NO972938L (no) Farmasöytiske piperazinforbindelser
DK0832079T3 (da) Antiiskæmiske hydroxylaminderivater og farmaceutiske sammensætninger
FR2757161B1 (fr) Diphenylalkyl-tetrahydropyridines
BR9812928A (pt) Novos derivados de 3-oxo-(2h) -1,2,4-triazina, processo de preparação de compostos quìmicos, e, composição farmacêutica
DE69624459D1 (de) Kondensierte indan-derivate und ihre salze
DK0687257T3 (da) 4-amino-2-(hetero)aryl-butanamider anvendelige som 5HT1A-antagonister
DK0651747T3 (da) Carbostyrilderivater

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee